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Summary	  Activin/Nodal	   growth	   factors	   control	   a	   broad	   range	   of	   biological	   processes	   including	  early	  cell	  fate	  decisions,	  organogenesis	  and	  adult	  tissue	  homeostasis.	  Here,	  we	  provide	  an	  overview	  of	  the	  mechanisms	  by	  which	  the	  Activin/Nodal	  signaling	  pathway	  governs	  stem	  cell	  function	  in	  these	  different	  stages	  of	  development	  and	  describe	  recent	  findings	  which	  associate	  Activin/Nodal	  signaling	  to	  pathological	  conditions,	   focusing	  on	  cancer	  stem	   cells	   in	   tumorigenesis	   and	   its	   potential	   as	   a	   target	   for	   therapies.	   Lastly,	  we	  will	  discuss	  future	  directions	  and	  questions	  that	  currently	  remain	  unanswered	  on	  the	  role	  of	  Activin/Nodal	  signaling	  in	  stem	  cell	  self-­‐renewal,	  differentiation	  and	  proliferation.	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Introduction	  Activin	   and	   Nodal	   are	   members	   of	   the	   Transforming	   Growth	   Factor	   β	   (TGFβ)	  superfamily	   of	   morphogens,	   which	   comprises	   at	   least	   42	   members	   in	   humans	   and	  includes	   inhibins,	   TGFβs,	   bone	   morphogenetic	   proteins	   (BMPs),	   growth	   and	  differentiation	   factor	   (GDF),	   myostatin,	   Müllerian-­‐inhibiting	   substance	   and	   others	  (Oshimori	  and	  Fuchs,	  2012a).	   	  The	  TGFβ	  superfamily	  is	  found	  in	  metazoans	  and	  arose	  alongside	  multicellularity,	  with	   the	  Nodal,	  Activin	  and	  BMP	   families	  considered	  as	   the	  most	  evolutionary	  ancient	  family	  members	  (Pang	  et	  al.,	  2011).	  Nodal	  was	  identified	  in	  mouse	   through	  a	  retroviral	   insertion	  mutagenesis	  screen	  (Robertson	  et	  al.,	  1986)	  and	  indicated	   a	   distinct	   expression	   in	   the	   node	   region	   while	   causing	   a	   striking	   defect	   in	  gastrulation	   upon	   its	   disruption	   (Conlon	   et	   al.,	   1991;	   Conlon	   et	   al.,	   1994;	   Zhou	   et	   al.,	  1993).	   The	   Nodal	   subfamily	   is	   present	   in	   most	   metazoans	   except	   Drosophila	   and	   C.	  elegans	   (Rebagliati	   et	   al.,	   1998).	   Activin	   was	   discovered	   in	   the	   1980s	   as	   a	   gonadal	  protein	   that	   induced	   Follicle	   Stimulating	   Hormone	   (FSH)	   release	   but	   since	   then	   has	  been	   found	   to	   be	   expressed	   in	   many	   different	   cell	   types	   at	   nearly	   all	   stages	   of	  development	  (Vale	  et	  al.,	  1986).	  Nodal	  and	  Activin	  ligands	  can	  both	  signal	  through	  the	  same	   receptors	   and	   effectors	   in	   order	   to	   regulate	   transcription.	   In	   many	   cases	   the	  effects	   of	  Nodal	   and	  Activin-­‐mediated	   signalling	   are	   indistinguishable;	   hence	   they	   are	  referred	   to	   as	   the	   Activin/Nodal	   pathway.	   Similarly,	   as	   discussed	   further	   below,	  Nodal/Activin	  and	  TGFβ	  pathway	   share	   the	  downstream	  effectors	  Smad2	  and	  Smad3.	  Thus,	  these	  pathways	  are	  often	  considered	  to	  have	  similar	  functions	  even	  though	  their	  tissue	  expression	  pattern	  is	  often	  different.	  	  Nodal	  was	  one	  of	  the	  first	  genes	  knocked	  out	  in	  mice	  (Collignon	  et	  al.,	  1996;	  Zhou	  et	  al.,	  1993)	  and	  its	  function	  in	  early	  development	  has	  been	  broadly	  studied	  in	  different	  model	  organisms.	  Of	  particular	  relevance,	  genetic	  studies	  in	  the	  mouse	  have	  established	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that	  Nodal	  signalling	  is	  necessary	  at	  the	  early	  epiblast	  stage	  during	  implantation	  where	  the	  pathway	  functions	  to	  maintain	  the	  expression	  of	  key	  pluripotency	  factors	  as	  well	  as	  regulate	   the	   differentiation	   of	   extra-­‐embryonic	   tissue.	   Activins,	   dimers	   of	   different	  subtypes	  of	   Inhibin	  β,	  are	  also	  expressed	  in	  pre-­‐implantation	  blastocyst	  but	  not	   in	  the	  primitive	  streak	  (Albano	  et	  al.,	  1993;	  Feijen	  et	  al.,	  1994).	  However,	  genetic	  studies	  have	  shown	  that	  Inhibins	  β	  are	  not	  necessary	  for	  early	  development	  in	  the	  mouse	  (Lau	  et	  al.,	  2000;	  Matzuk,	  1995;	  Matzuk	  et	  al.,	  1995a;	  Matzuk	  et	  al.,	  1995b).	  Combined	  gradients	  of	  Nodal	  and	  BMP	  signalling	  within	  the	  primitive	  streak	  control	  endoderm	  and	  mesoderm	  germ	   layer	   specification	   and	   also	   their	   subsequent	   patterning	   whilst	   blocking	  neuroectoderm	   formation	   (Camus	   et	   al.,	   2006;	   Mesnard	   et	   al.,	   2006).	   Following	  implantation,	   a	   gradient	  of	  Nodal	   signalling	  defines	   the	  proximal–distal	   axis,	  which	   in	  turn	   establishes	   the	   anterior–posterior	   axis	   of	   the	   developing	   embryo	   (Arnold	   and	  Robertson,	   2009).	   At	   later	   stages	   of	   embryogenesis,	   Nodal	   governs	   left–right	   axis	  asymmetry	   and	   further	   patterning	   of	   the	   neural	   and	   gut	   tubes	   (Brennan	   et	   al.,	   2002;	  Saijoh	  et	  al.,	  2003;	  Schier	  et	  al.,	  1997).	  In	  parallel,	  a	  vast	  number	  of	  studies	  have	  shown	  that	   Activin/Nodal	   morphogens	   regulate	   a	   range	   of	   cellular	   processes	   including	   cell	  cycle	   progression,	   progenitors	   proliferation/differentiation	   during	   organogenesis	  (Brennan	  et	  al.,	  2001;	  Feldman	  et	  al.,	  1998;	  Gritsman	  et	  al.,	  2000),	  as	  well	  as	  adult	  tissue	  homeostasis	   in	   some	   tissues	   (Strizzi	   et	   al.,	   2012).	   Of	   note,	   deregulation	   of	   TGFβ	   and	  Activin/Nodal	   signalling	   pathways	   also	   plays	   a	   prominent	   role	   in	   tumorigenesis	   and	  metastasis	   (Massague,	  2008),	  which	  may	  be	  related	   to	   the	   function	  of	   these	  signalling	  pathways	  in	  embryonic	  development.	  	  Consistent	  with	  its	  role	  in	  the	  epiblast	  stage,	  Nodal/Activin	  signalling	  has	  recently	  been	  shown	  to	  maintain	  pluripotency	  in	  human	  pluripotent	  stem	  cells	  (hPSCs)	  (Vallier	  et	  al.,	  2004)	  and	  also	  in	  mouse	  epiblast	  stem	  cells	  (mEpiSCs)	  (Brons	  et	  al.,	  2007).	  This	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function	   is	  achieved	   through	  complex	   interactions	  with	  pluripotency	   factors	   including	  Nanog	  (Vallier	  et	  al.,	  2009a)	  and	  also	  by	  cross-­‐talk	  with	  cell	  cycle	  related	  mechanisms	  (Pauklin	  and	  Vallier,	  2013).	  	  The	  near	  ubiquitous	  activity	  of	  Activin,	  Nodal	  and	  TGFβ	  during	  development	  and	  their	  function	  in	  tissues	  containing	  well	  established	  adult	  stem	  cells	  tentatively	  suggest	  that	   the	   function	  of	  Activin/Nodal	  signaling	   in	  self-­‐renewal	  could	  be	  conserved	  across	  embryonic	  and	  tissue-­‐specific	  adult	  stem	  cells.	  In	  this	  review	  we	  discuss	  the	  role	  of	  Activin/Nodal	  signaling	  pathways	  in	  mediating	  pluripotency	   and	   early	   cell	   fate	   decisions,	   embryonic	   development,	   adult	   tissue	  homeostasis	   and	   tumorigenesis,	   with	   the	   aim	   to	   identify	   common	   stem	   cell	   related	  mechanisms.	  We	  also	  briefly	  discuss	  the	  function	  TGFβ	  signalling	  in	  these	  processes	  and	  the	  similarities	  with	  its	  sibling	  pathway	  Activin/Nodal.	  
	  
Activin/Nodal	  signaling	  pathway	  
Ligands	  and	  Receptors	  Nodal	   is	   synthesized	   as	   precursor,	   with	   a	   large	   pro-­‐domain	   and	   a	   mature	   carboxy-­‐terminal	  domain,	  which	  is	  cleaved	  by	  pro-­‐protein	  convertases	  Spc1	  and	  Spc4	  (Constam	  and	   Robertson,	   2000)	   to	   generate	   an	   active	   protein.	   Nodal	   forms	   homomeric	   dimers	  which	  are	  held	   together	  by	  disulphide	  bonds.	  There	   is	  only	  one	  Nodal	  gene	   in	  mouse,	  human	  and	  birds	  (Zhou	  et	  al.,	  1993),	  three	  in	  zebrafish	  (Erter	  et	  al.,	  1998;	  Feldman	  et	  al.,	  1998;	   Rebagliati	   et	   al.,	   1998;	   Sampath	   et	   al.,	   1998)	   and	   five	   in	   Xenopus	   (Jones	   et	   al.,	  1995;	   Joseph	   and	  Melton,	   1997).	   In	   contrast,	   Activins	   are	   formed	   by	   homodimers	   or	  heterodimers	   of	   inhibin	   subunits	   (βa,	   βb,	   βc,	   βe)	   which	   are	   also	   held	   together	   by	   a	  disulphide	  bond.	  	  The	  combination	  of	  different	  inhibin	  subunits	  results	  in	  a	  diversity	  of	  Activins	   with	   Activin	   A	   (inhibin	   βa	   dimer),	   B	   (inhibin	   βb	   dimer)	   and	   AB	   (dimer	   of	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inhibin	   βa	   and	   βb),	   being	   the	   most	   studied	   and	   the	   most	   evolutionary	   conserved.	  Genetic	  studies	  have	  shown	  that	  Inhibin	  βa	  and	  βb	  subunits	  have	  different	  functions	  in	  late	  development	  and	  adult	   tissues	  (Matzuk,	  1995;	  Matzuk	  et	  al.,	  1995a;	  Matzuk	  et	  al.,	  1995b)	  while	  Inhibin	  βc	  and	  βe	  do	  not	  appear	  necessary	  for	  normal	  development	  and	  homeostasis	  (Lau	  et	  al.,	  2000).	  Activins	   and	  Nodal	   exert	   their	   biological	   effects	   by	   interacting	  with	   two	   types	   of	  transmembrane	   receptors	   (types	   I	   and	   II),	   which	   have	   intrinsic	   serine/threonine	  kinase	   activities	   in	   their	   cytoplasmic	   domains	   (Figure	   1	   and	   Table	   1)	   (Wrana	   et	   al.,	  1994).	   Activin/Nodal	   bind	   to	   type	   II	   Activin	   receptors	   (ActRII/IIB),	   leading	   to	   the	  recruitment,	   phosphorylation,	   and	   activation	   of	   type	   I	   Activin	   receptors	   (Activin	  receptor-­‐like	  kinases	  –	  ALKs,	  including	  ALK1–7)	  and	  in	  particular	  ALK4,	  also	  known	  as	  ActRIB	   (Tsuchida	  et	  al.,	  2004).	   	  The	  serine/threonine	  kinase	   receptors	  ActRII/IIB	  and	  Alk4/7	   then	   trigger	   the	   phosphorylation	   of	   the	   Smad	   transcription	   factors,	   discussed	  further	  below	   (Wrana	   et	   al.,	   1994).	  Of	  note,	  TGFβ	  members	  bind	   to	   a	  different	   set	  of	  receptors	  TGFBRI	  and	  TGFBRII	  (or	  Alk5)	  (Figure	  1).	  	  Activin/Nodal	   often	   act	   as	   morphogens	   (Box1)	   and	   their	   activity	   is	   regulated	   by	  multiple	   mechanisms	   including	   extracellular	   antagonists	   (Lefty1/2,	   Cerberus,	  Follistatin)	   and	   agonists	   (Cripto),	   processing	   enzymes	   (Spc1,	   Spc4),	   intracellular	  molecules	  (Smad6/7,	  TMEPA1)	  and	  co-­‐regulators	  (FoxH1),	  as	  well	  as	  proteins	  involved	  in	   receptor	   trafficking	   and	   miRNAs	   (Schier,	   2009)	   (Figure	   1	   and	   Table	   1).	   These	  mechanisms	   coordinate	   the	   activity	   and	   tissue	   specificity	   of	   this	   important	   signaling	  pathway	  in	  different	  cellular	  and	  developmental	  contexts.	  	  
Smads	  and	  Smad-­‐binding	  transcriptional	  regulators	  The	  Activin/Nodal	  pathway	  exerts	  its	  effects	  by	  orchestrating	  transcriptional	  networks	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controlling	   gene	   expression	   and	   downstream	   cellular	   processes.	   This	   is	  mediated	   by	  three	  classes	  of	  Smad	  proteins;	  the	  receptor-­‐regulated	  R-­‐Smads,	  the	  common-­‐mediator	  Co-­‐Smads	  and	  the	  inhibitory	  I-­‐Smads.	  Smad1/5/8	  signalling	  is	  activated	  by	  other	  TGFβ	  superfamily	  members	  such	  as	  BMP	  while	  Activin/Nodal	  and	  TGFβ	  signalling	  pathways	  are	  specifically	  mediated	  through	  Smad2	  and	  Smad3	  (R-­‐Smads),	  Smad4	  (Co-­‐Smad)	  and	  Smad7	  (I-­‐Smad)	  (Figure	  1,	  Table	  2)	  (Shi	  and	  Massague,	  2003).	  Smad2	  and	  Smad3	  form	  a	   complex	   (Smad2/3)	   in	   the	   cytoplasm,	   which	   interact	   with	   Smad4	   after	  phosphorylation	   and	   then	  moves	   into	   the	   nucleus.	   R-­‐Smads	   and	   Co-­‐Smads	   contain	   a	  highly	   conserved	   amino-­‐terminal	   Mad	   homology	   MH1	   domain,	   a	   weakly	   conserved	  linker	   region,	   and	   the	   carboxyl-­‐terminal	   MH2	   domain	   (Figure	   2)(Massague	   et	   al.,	  2005).	  The	  MH1	  domain	  mediates	  the	  binding	  of	  Smads	  to	  DNA	  and	  their	  interaction	  with	   other	   transcription	   factors.	   The	   MH2	   domain	   is	   involved	   in	   transcriptional	  activation,	  interaction	  between	  Smad	  proteins	  or	  its	  transmembrane	  receptors,	  as	  well	  as	   its	   binding	   to	   various	   transcription	   factors	   (Wrana,	  2000).	  Phosphorylation	  of	   the	  linker	  region	  of	  Smads	  affects	  their	  stability	  and	  their	  movement	  to	  the	  nucleus	  -­‐	  thus	  regulating	   the	   abundance	   of	   Smad	   proteins	   on	   the	   chromatin	   (Kretzschmar	   et	   al.,	  1999).	   The	   linker	   domain	   also	   mediates	   Smads	   proteasome-­‐mediated	   degradation	  through	   	   interaction	  with	  Smurf	  proteins	   (Zhang	  et	  al.,	  2001).	   In	  addition,	  Smad2/3	  is	  activated	   by	   receptor-­‐mediated	   phosphorylation	   and	   inhibited	   by	   phosphatases	   such	  as	  PPM1A	  (Lin	  et	  al.,	  2006).	  Dephosphorylated	  Smad2/3	  is	  then	  recognized	  by	  RanBP3	  and	  exported	  out	  of	  the	  nucleus	  (Dai	  et	  al.,	  2009).	  	  Smad4	   and	   the	   R-Smads,	   with	   the	   exception	   of	   Smad2,	   bind	   directly	   to	   DNA	  although	  with	  low	  affinity	  and	  low	  specificity	  (Ross	  and	  Hill,	  2008).	  Smad3	  and	  Smad4	  recognize	   a	   Smad-­‐binding	   element	   (SBE),	   which	   consists	   of	   AGAC	   or	   its	   reverse	  complement.	   In	   order	   to	   achieve	  higher	   affinity	   and	   selectivity	   for	  DNA	  binding	   sites,	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Smad	  proteins	  can	  also	  associate	  with	  various	  tissue-­‐specific	  transcription	  factors	  (see	  Table	   2)	   which	   mediate	   a	   range	   of	   processes	   including	   pluripotency	   (Mullen	   et	   al.,	  2011)	  (Suzuki	  et	  al.,	  2006;	  Vallier	  et	  al.,	  2009a),	  mesendoderm	  specification	  (Teo	  et	  al.,	  2011),	  muscle	  cell	  (Mullen	  et	  al.,	  2011)	  and	  hematopoietic	  differentiation	  (Trompouki	  et	  al.,	  2011).	  The	  Smad2/3	  transcription	  factor	  complex	  can	  additionally	  recruit	  positive	  or	  negative	   regulators	   of	   transcription	   such	   as	   histone	   acetyltransferase	   CBP/p300	   or	  histone	   deacetylases	   HDAC1-­‐6,	   respectively.	   Smad2/3	   can	   also	   cooperate	   with	   co-­‐regulators	   SWI/SNF,	   MEDIATOR/ARC105	   and	   NuRD	   in	   inducing	   or	   repressing	   the	  expression	  of	  various	  target	  loci	  (Ross	  and	  Hill,	  2008).	  The	  resulting	  complexes	  (Smad-­‐transcription	   factors-­‐Cofactors)	   ensure	   a	   cell	   type-­‐specific	   transcriptional	   response,	  either	   by	   activating	   or	   repressing	   transcription,	   which	   thereby	   enables	   Smad2/3	   to	  control	  a	  range	  of	  mechanisms	  with	  sometimes	  opposing	  functions	  (Mullen	  et	  al.,	  2011).	  	  
Activin/Nodal	  signaling	  in	  embryonic	  stem	  cells	  
Activin/Nodal	  signaling	  in	  pluripotency	  The	   function	   of	   Activin/Nodal	   signalling	   in	   germ	   layer	   specification	   has	   been	   broadly	  studied	  in	  model	  organisms:	  first	  in	  the	  mouse	  embryo	  (Conlon	  et	  al.,	  1991;	  Zhou	  et	  al.,	  1993)	  and	  later	  in	  Xenopus	  (Jones	  et	  al.,	  1995),	  and	  Zebrafish	  (Feldman	  et	  al.,	  1998).	  It	  was	   initially	   found	   that	   Activin/Nodal	   signalling	   was	   necessary	   for	   endoderm	  specification	  (Jones	  et	  al.,	  1995;	  Zhou	  et	  al.,	  1993)	  and	  this	  view	  remained	  unchallenged	  until	   in	   vitro	   studies	   in	   human	   embryonic	   stem	   cells	   (hESCs)	   suggested	   that	  Activin/Nodal	  signalling	  was	  necessary	  and	  sufficient	  to	  maintain	  the	  pluripotent	  status	  of	   the	  post-­‐implantation	  epiblast	  (Vallier	  et	  al.,	  2004).	  This	   initial	  report	  was	  followed	  by	  in	  vivo	   	  studies	  in	  mouse	  showing	  that	  the	  absence	  of	  Nodal	  signalling	  results	  in	  the	  loss	  of	  pluripotency	  markers	  and	  the	  gain	  of	  ectopic	  neuroectoderm	  marker	  expression	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in	  the	  epiblast	  immediately	  following	  implantation	  (Camus	  et	  al.,	  2006;	  Mesnard	  et	  al.,	  2006)	   (Figure	   4).	   Therefore,	   Activin/Nodal	   signalling	   appears	   to	   operate	   via	   similar	  mechanisms	   during	   both	   in	   the	   mouse	   epiblast	   and	   in	   hESCs	   grown	   in	   vitro.	   This	  hypothesis	  was	  confirmed	  by	  the	  derivation	  of	  epiblast	  stem	  cells	  (EpiSCs)	   from	  post-­‐implantation	  mouse	   embryo	   using	   defined	   culture	  media	   containing	   Activin	   and	   FGF	  (Brons	   et	   al.,	   2007).	   Similarly	   to	   hESCs,	   EpiSCs	   rely	   on	   Activin/Nodal	   signalling	   to	  undergo	   self-­‐renewal,	   while	   chemical	   inhibition	   of	   the	   Alk4/7	   receptors	   drive	   their	  differentiation	   toward	   the	   neuroectoderm	   pathway.	   Furthermore,	   the	   same	   culture	  conditions	   can	   be	   used	   to	   induce	   differentiation	   of	   mouse	   EpiSCs,	   hESCs	   and	   human	  induced	   pluripotent	   stem	   cells	   (hiPSCs)	   into	   derivatives	   of	   the	   three	   germ	   layers,	  confirming	   that	   these	   pluripotent	   cells	   rely	   on	   the	   same	   set	   of	   signalling	   pathways,	  including	  Activin/Nodal,	  to	  control	  their	  cell	  fate	  decisions	  (Vallier	  et	  al.,	  2009b;	  Vallier	  et	   al.,	   2009c).	   Taken	   together,	   these	   reports	   lead	   to	   the	   conclusion	   that	   hPSCs	   and	  EpiSCs	   share	   a	   similar	   pluripotency	   state	   characterised	   by	   their	   dependency	   on	  Activin/Nodal	  signalling.	  	  	   Nevertheless,	   hESCs	   and	   EpiSCs	   are	   not	   strictly	   identical:	   contrary	   to	   EpiSCs,	  	  hESCs	  express	  pre-­‐implantation	  markers	  such	  as	  Rex1	  (Chan	  et	  al.,	  2009)	  and	  not	  post-­‐implantation	   markers	   such	   as	   FGF5	   (Vallier	   et	   al.,	   2004),	   and	   also	   can	   exhibit	   X	  activation,	   indicative	   of	   pre-­‐implantation	   stages	   (Lengner	   et	   al.,	   2010;	   Tomoda	   et	   al.,	  2012).	   These	   observations	   could	   underline	   species	   divergence.	   Indeed,	   human	   and	  mouse	   seem	   to	   use	   different	   signalling	   pathways	   during	   their	   early	   development	  (Nichols	  et	  al.,	  2001).	  Therefore,	  Activin/Nodal	  signalling	  could	  have	  an	  early	   function	  in	  human	  pre-­‐implantation	  embryos,	  which	  could	  be	  masked	  by	  redundant	  mechanisms	  in	   the	  mouse	  embryo	  between	  TGFβs	  and	  Activin/Nodal	   signalling	   (Sato	  et	   al.,	   2003).	  Basic	   studies	   on	   human	   embryo	   using	   recent	   advances	   in	   single	   cell	   gene	   expression	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profiling	   could	   be	   advantageous	   to	   confirm	   this	   hypothesis.	   These	   results	   would	   be	  essential	  to	  develop	  new	  culture	  systems	  for	  the	  derivation	  of	  “Inner	  Cell	  Mass”	  (ICM)-­‐like	  ESCs	  and	  help	  to	  dissipate	  the	  controversy	  concerning	  the	  existence	  of	  ground	  state	  hESCs	  (Gafni	  et	  al.,	  2013).	  	  FGF	  is	  also	  necessary	  to	  maintain	  the	  expression	  of	  pluripotency	  markers	  in	  hESCs	  (Levenstein	   et	   al.,	   2006).	   Nevertheless,	   chemical	   inhibition	   of	   FGF	   receptors	   can	   be	  rescued	   by	   increasing	   the	   quantity	   of	   exogenous	   Activin	   whereas	   absence	   of	   Activin	  signalling	  cannot	  be	  reversed	  by	  high	  dose	  of	  FGF	  (Vallier	  et	  al.,	  2005).	  Therefore,	  FGF	  signalling	  appears	  to	  synergise	  with	  Activin	  to	  regulate	  pluripotency	  rather	  than	  to	  act	  independently	   (Figure	   4).	   This	   mechanism	   could	   involve	   Sox2	   since	   this	   gene	   is	  regulated	  in	  hPSCs	  by	  ERK2,	  an	  effector	  of	  the	  FGF	  signalling	  (Yu	  et	  al.,	  2011).	  Thus,	  FGF	  may	   support	   the	   function	   of	   Activin/Nodal	   signalling	   in	   hESCs	   by	   activating	   a	  complementary	  transcriptional	  network	  (Goke	  et	  al.,	  2013).	  	  	   Although	   Nodal/Activin	   signalling	   is	   crucial	   to	   maintain	   pluripotency	   in	   the	  murine	  epiblast	  and	  derived	  cells,	  the	  function	  of	  this	  signalling	  pathway	  in	  mouse	  ESCs	  remains	   unclear.	   Indeed,	   overexpression	   of	   Smad6/7	   in	   mESCs	   grown	   in	   foetal	   calf	  serum	   only	   decreases	   their	   proliferation	   suggesting	   that	   TGFβ/Activin/Nodal	   are	   not	  required	  for	  their	  pluripotency	  (Ogawa	  et	  al.,	  2007).	  Furthermore,	  genetic	  studies	  in	  the	  mouse	  have	  not	  revealed	  any	   function	   for	  Activin/Nodal	  signalling	   in	  embryos	  at	  pre-­‐implantation	  stages.	  Despite	  these	  observations,	  some	  evidence	  suggests	  a	  possible	  role	  for	   Activin/Nodal	   signalling	   in	  mouse	   ESCs.	   Chromatin	   immunoprecipitation	   analyses	  combined	  with	  deep	   sequencing	   (ChIP-­‐Seq)	   analyses	   showed	  binding	  of	   the	   Smad2/3	  complex	   to	   Oct4	   locus	   in	   mESCs	   grown	   in	   the	   absence	   of	   serum,	   while	   chemical	  inhibition	  of	  ALK4/7	   induces	  differentiation	   toward	   trophectoderm	   (Lee	  et	   al.,	   2011).	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Further	  investigations	  are	  therefore	  necessary	  to	  define	  more	  clearly	  the	  importance	  of	  Activin/Nodal	  signalling	  in	  mESCs.	  	  Interestingly,	   mESCs	   appear	   to	   rely	   on	   fundamentally	   different	   mechanisms	   of	   self-­‐renewal	   when	   compared	   to	   hESCs.	   A	   popular	   model	   for	   this	   implies	   that	   mESC	  pluripotency	  does	  not	  require	  an	  inductive	  signalling	  pathway	  but	  rather,	  that	  it	  is	  the	  result	   of	   a	   passive	   balance	   between	   different	   signalling	   pathways	   repressing	  differentiation	  (i.e.	  LIF	  blocks	  mesendoderm	  while	  BMP4	  blocks	  neuroectoderm)	  or	  the	  total	  absence	  of	  inductive	  signals	  of	  differentiation	  (2i	  +	  LIF	  system)	  (Ying	  et	  al.,	  2003;	  Ying	   et	   al.,	   2008).	   Accordingly,	   mESCs	   self-­‐renewal	   can	   be	   stabilised	   by	   chemically	  inhibiting	   GSK3β	   and	   the	   ERK	   kinase	   pathway	   in	   the	   absence	   of	   exogenous	   growth	  factors,	   confirming	   that	   extra-­‐cellular	   stimuli	   are	   not	   required	   for	   pluripotency	   in	  mESCs.	  	  The	  situation	  is	  fundamentally	  different	  in	  hESCs	  where	  Activin	  plays	  a	  direct	  and	  inductive	   role	   not	   only	   in	   blocking	   neuroectoderm	   differentiation	   but	   also	   in	  maintaining	  the	  expression	  of	  key	  pluripotency	  factors	  such	  as	  Oct4,	  and	  Nanog	  (Vallier	  et	   al.,	   2009a).	   Smad2/3	   also	   directly	   interact	  with	   Oct4	   and	  Nanog	   across	   a	   range	   of	  promoters	   and	   may	   be	   necessary	   for	   the	   activity	   of	   these	   factors.	   Consequently,	   the	  Smad2/3	   complex	   is	   fully	   integrated	   into	   the	   transcriptional	   network	   characterising	  hESCs	  and	  loss	  of	  Smad2/3	  transcriptional	  activity	  consistently	  results	  in	  differentiation	  (Vallier	   et	   al.,	   2009a).	   The	   use	   of	   chemical	   inhibitors	   remains	   largely	   inadequate	   to	  maintain	   pluripotency	   in	   hESCs	   underscoring	   once	   again	   that	   pluripotency	   state	   of	  hESCs	   and	  mESCs	   are	   conceptually	   different.	   Interestingly,	   	   the	   attempts	   to	   generate	  ground	   state-­‐like	  hESCs	  directly	   from	  embryos	  either	   include	   an	   exogenous	   source	  of	  TGFβ	   and/or	   chemical	   inhibition	   of	   Alk-­‐4/7	   induces	   differentiation	   of	   the	   resulting	  pluripotent	  stem	  cells	  (Gafni	  et	  al.,	  2013;	  Theunissen	  et	  al.,	  2014).	  This	  suggests	  that	  the	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role	   of	   TGFβ	   in	   the	   pre-­‐implantation	   human	   embryo	   has	   been	   underestimated	   and	  deserves	  further	  investigation.	  	  Importantly,	   the	   Smad2/3	   complex	   can	   be	   found	   on	   a	   range	   of	   mesendoderm	  genes,	  even	  in	  undifferentiated	  hESCs	  or	  in	  EpiSCs,	  and	  this	  binding	  could	  explain	  why	  transcripts	   of	   differentiation	   markers	   can	   be	   detected	   either	   by	   Q-­‐PCR	   or	   gene	  expression	   array	   in	   these	   cell	   types	   (Brown	   et	   al.,	   2011).	   Indeed,	   the	   presence	   of	   the	  Smad2/3	   complex	   on	   these	   promoters	   could	   result	   in	   transcriptional	   leakiness,	  producing	   significant	   amounts	   of	   these	   transcripts	   that	   are	   usually	   associated	   with	  differentiated	   cells.	   This	   phenomenon	   has	   little	   or	   no	   phenotypic	   effects	   since	   the	  proteins	  of	  the	  corresponding	  genes	  cannot	  be	  detected.	  Interestingly,	  a	  broad	  number	  of	  these	  genes	  display	  bivalent	  histone	  marks	  (positive	  and	  negative),	  which	  have	  been	  shown	  to	  prime	   transcription	   in	  stem	  cells	   (Pan	  et	  al.,	  2007).	  Activin/Nodal	  signalling	  via	  Smad2/3	  could	  therefore	  maintain	  pluripotency	  but	  also	  enable	  hESCs	  to	  prime	  the	  expression	  of	  tissue-­‐specific	  differentiation	  genes,	  thus	  allowing	  rapid	  cell	  fate	  choices.	  This	  supports	  the	  concept	  that	  hESCs	  may	  represent	  a	  primed	  state	  of	  pluripotency	  as	  opposed	  to	  the	  ground	  state	  observed	  in	  mESCs.	  However,	  mESCs	  grown	  in	  serum	  are	  also	  “primed”	  to	  differentiate	  toward	  extra-­‐embryonic	  tissues	  (Niwa	  et	  al.,	  2005)	  or	  to	  progress	   toward	   the	   epiblast	   stage	   (Toyooka	  et	   al.,	   2008).	  Thus,	   “priming“	   could	  be	   a	  common	  mechanism	  between	  stem	  cells	  since	  the	  main	  objective	  of	  this	  cell	  type	  in	  vivo	  is	   not	   to	   self-­‐renew	   but	   to	   generate	   the	   necessary	   cells	   for	   normal	   development	   and	  organogenesis.	  	  	  
Activin/Nodal	  signaling	  as	  inducer	  of	  endoderm	  differentiation	  Despite	  its	  essential	  activity	  in	  maintaining	  pluripotency,	  Activin/Nodal	  signaling	  is	  also	  absolutely	   required	   for	   endoderm	   differentiation	   (Arnold	   and	   Robertson,	   2009;	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D'Amour	   et	   al.,	   2005;	   Kubo	   et	   al.,	   2004).	   Accordingly,	   inhibition	   of	   Activin/Nodal	  signaling	  blocks	   the	  expression	  of	  endoderm	  markers	  and	  promotes	  the	  expression	  of	  mesoderm	  markers	  in	  the	  presence	  of	  BMP4	  in	  vitro	  (Kubo	  et	  al.,	  2004)	  and	  in	  a	  broad	  number	  of	  species	  (Chen	  and	  Schier,	  2001).	  	  Activin/Nodal	  signalling	  achieves	   this	   function	  by	   interacting	  with	  other	  key	  signaling	  pathways,	   especially	   BMP	   and	   WNT	   (Tam	   and	   Loebel,	   2007).	   The	   molecular	  mechanisms	   involved	   in	   this	   cross-­‐talk	   among	   pathways	   have	   been	   particularly	   well	  studied	  in	  amphibian	  and	  fish	  where	  it	  has	  been	  shown	  that	  BMP-­‐Smad1/5/8	  interact	  with	  mesoderm	  regulators	  such	  as	  Brachyury	  to	  repress	  endoderm	  markers,	  induced	  by	  Nodal-­‐Smad2/3	  (Garnett	  et	  al.,	  2009;	  Messenger	  et	  al.,	  2005;	  Morley	  et	  al.,	  2009).	  At	  the	  same	  time,	  WNT	  signaling	  also	  plays	  an	  essential	  function	  in	  mesendoderm	  specification	  by	   controlling	   the	   expression	   of	   Nodal	   and	   its	   co-­‐receptor	   Cripto	   during	   gastrulation	  (Tam	  and	  Loebel,	  2007).	  	  Importantly,	  genome	  wide	  analyses	  performed	  on	  hESCs	  differentiating	  into	  endoderm	  have	  shown	  that	  the	  Smad2/3	  complex	  directly	  controls	  the	  transcriptional	  activity	  of	  a	  broad	   number	   of	   endoderm	   genes	   (Brown	   et	   al.,	   2011).	   Thus,	   the	   transcriptional	  network	  driving	  endoderm	  specification	  is	  ultimately	  orchestrated	  by	  Smad2/3	  and	  its	  partners	   (Table	   2,	   Figure	   4).	   BMP	   and	  WNT	   could	   be	   required	   only	   to	   initiate	   and	   to	  stabilize	   this	   network,	   respectively.	   Accordingly,	   BMP	   plays	   a	   crucial	   role	   in	   vitro	   to	  block	  the	  protective	  activity	  of	  Activin/Nodal	  signalling	  on	  pluripotency	  and	  to	  promote	  the	   induction	   of	   endoderm	   specification	   (Sakaki-­‐Yumoto	   et	   al.,	   2013).	   Furthermore,	  WNT/β-­‐catenin	   interacts	   with	   Smad2/3	   target	   genes	   such	   as	   Sox17	   to	   activate	   the	  expression	  of	  other	  genes	   such	  as	  FoxA2	   (Sinner	  et	   al.,	   2004),	  which	  are	  essential	   for	  endoderm	  pattering	   and	   organogenesis.	   Further	   genome	   analyses	   detailing	   the	   target	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genes	   downstream	   of	   Smad1/5/8	   and	   β-­‐catenin	   could	   help	   to	   further	   uncover	   the	  nature	  of	  the	  molecular	  cross	  talk	  between	  Activin/Nodal,	  WNT	  and	  BMP.	  	   The	   mechanisms	   by	   which	   Activin/Nodal	   signalling	   maintains	   pluripotency	  while	  inducing	  endoderm	  differentiation	  also	  remain	  to	  be	  fully	  elucidated	  and	  several	  studies	   have	   started	   to	   reveal	   some	   important	   regulatory	   mechanisms.	   ChIP-­‐Seq	  analyses	   showed	   that	   the	   location	   of	   Smad2/3	   binding	   in	   the	   genome	   changes	   upon	  endoderm	   differentiation,	   suggesting	   that	   the	   specificity	   of	   Activin/Nodal	   signalling	  might	  be	  defined	  by	  the	  genomic	  location	  of	  its	  binding	  partners	  (Brown	  et	  al.,	  2011).	  	  Interestingly,	  the	  transcriptional	  networks	  downstream	  of	  Smad2/3	  and	  Nanog,	  as	  well	  as	  Oct4,	   significantly	  overlap	   in	  hESCs,	  which	   further	  points	   to	   a	  potential	   interaction	  between	  these	  factors.	  Co-­‐immunoprecipitation	  analyses	  have	  shown	  that	  Smad2/3	  and	  Nanog	  could	  be	  part	  of	  the	  same	  protein	  complex	  in	  hESCs,	  and	  that	  they	  cooperate	  to	  orchestrate	   the	   transcriptional	   network	   characterizing	   hPSCs	   (Vallier	   et	   al.,	   2009a).	  Further	   studies	  have	  also	   revealed	  an	   interaction	  between	  Smad2/3	  and	  Eomes	  upon	  mesendoderm	   specification	   (Teo	   et	   al.,	   2011).	   Therefore,	   it	   is	   possible	   to	   consider	   a	  model	  in	  which	  Smad2/3	  switch	  binding	  partners	  during	  differentiation,	  allowing	  a	  cell	  type	  specific	  outcome	  of	  the	  Activin/Nodal	  signaling.	  	  The	  model	   proposed	   above	   also	   suggests	   that	   inhibition	   of	   Nanog	   expression	   is	  necessary	  to	  enable	  Smad2/3	  to	  interact	  with	  Eomes	  and	  thus,	  to	  redirect	  the	  activity	  of	  Activin/Nodal	   signaling	   towards	   endoderm	   formation.	   This	   inhibition	   is	   likely	   to	   be	  induced	   by	   one	   or	   more	   signaling	   pathways,	   which	   could	   be	   considered	   as	   the	   true	  inducer	  of	  differentiation.	  WNT	  and	  BMP	  signaling	  are	  the	  most	  likely	  candidates:	  their	  function	  in	  endoderm	  and	  mesoderm	  specification	  has	  been	  studied	  in	  amphibians,	  fish	  and	  mouse	  and	  they	  are	  often	  included	  in	  the	  cocktail	  of	  growth	  factors	  used	  to	  generate	  endoderm	   from	  hPSCs	   in	  vitro.	   Importantly,	   Activin/Nodal	   signaling	   cannot	   fulfill	   this	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function	   alone,	   since	   even	   high	   doses	   of	   exogenous	   Activin/Nodal	   only	   reinforce	   the	  expression	  of	  pluripotent	  markers	  in	  hPSCs	  (Vallier	  et	  al.,	  2005).	  	  In	  addition	  to	  its	  role	  in	  primitive	  streak	  and	  mesoderm	  induction,	  BMP4	  has	  also	  been	  shown	  to	   induce	   the	  differentiation	  of	  hESCs	   toward	  extra-­‐embryonic	   tissue	  and	  this	   effect	   can	   be	   blocked	   by	   Activin/Nodal	   (Vallier	   et	   al.,	   2009c).	   Furthermore,	  Smad1/5/8	   and	   Smad2/3,	   which	   mediate	   BMP	   and	   Activin/Nodal	   signaling,	  respectively,	  bind	  to	  the	  same	  region	  of	  the	  Nanog	  promoter,	  suggesting	  that	  BMP4	  and	  Activin/Nodal	  may	   compete	   to	  modulate	   the	   expression	   of	   key	   pluripotency	  markers	  (Xu	  et	  al.,	  2008).	  BMP4	  can	  also	   induce	  differentiation	  by	  activating	   the	  expression	  of	  Eomes,	   which	   then	   feeds	   into	   the	   Smad2/3	   transcriptional	   network	   and	   ultimately	  repress	  the	  expression	  of	  Nanog	  (Teo	  et	  al.,	  2011).	  	  WNT	   signaling	   also	   plays	   a	   key	   function	   in	   controlling	   Activin/Nodal	   signaling	  since	   blocking	   the	   PI3K/Erk	   pathway	   and	   thereby	   inhibiting	   GSK3β	   are	   sufficient	   to	  induce	  endoderm	  differentiation	  of	  hESCs	   (Singh	  et	  al.,	  2012).	  Furthermore,	  β-­‐catenin	  and	   the	   Smad2/3	   complex	   have	   been	   shown	   to	   converge	   on	  mesendoderm	   genes	   to	  activate	  their	  transcriptional	  activity	  (Bernardo	  et	  al.,	  2011).	  Considered	  together,	  these	  reports	  support	  the	  role	  of	  WNT	  in	  modulating	  the	  activity	  of	  Activin/Nodal	  signaling.	  Nevertheless,	   the	   molecular	   mechanisms	   by	   which	   this	   synergy	   takes	   place	   remains	  unknown	  and	   further	  molecular	  analyses	  are	  necessary	   to	   fully	  understand	   the	  cross-­‐talk	  between	  Smad2/3	  and	  GSK3β/β-­‐catenin.	  	  Finally,	   a	   recent	   study	   showed	   that	   the	   Hippo	   pathway	   can	   repress	   Smad2/3	  transcriptional	  activity	  on	  endoderm	  genes	  in	  hESCs	  and	  thus,	  maintain	  the	  pluripotent	  state	  and	  block	  mesendoderm	  induction	  (Beyer	  et	  al.,	  2013).	  However,	  this	  mechanism	  seems	   to	   be	   limited	   to	   primitive	   streak	   genes	   such	   as	   Brachyury	   and	   is	   cell	   culture	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dependent,	   suggesting	   the	   existence	   of	   additional	   mechanisms	   involving	   inductive	  signals	  of	  differentiation.	  	  Considered	  together,	  these	  observations	  illustrate	  how	  Activin/Nodal	  signaling	  is	  interconnected	   with	   other	   signaling	   pathways,	   enabling	   Smad2/3	   to	   have	   divergent	  functions	   in	   different	   cell	   types	   (self-­‐renewal	   versus	   differentiation)	   and	   to	   control	   a	  diversity	  of	  biological	  process	  within	  the	  same	  cell	  type.	  However,	  the	  precise	  function	  and	  specificity	  of	  Smad2/3	   in	  all	   these	  cellular	  processes	  remains	  unclear.	   Indeed,	   the	  model	   proposed	   above	   explains	   in	   part	   that	   the	   tissue-­‐specific	   activity	   of	   Smad2/3	   is	  dictated	   by	   tissue	   specific	   transcription	   factors,	   however,	   it	   does	   not	   provide	   the	  molecular	   mechanism	   by	   which	   Smad2/3	   can	   interact	   with	   so	   many	   factors	   while	  retaining	  its	  specificity	  of	  action.	  Proteomic	  studies	  in	  combination	  with	  DNA	  pull	  down	  methods	  could	  help	  to	  identify	  the	  partners	  that	  co-­‐operate	  with	  Smad	  proteins	  to	  enact	  different	   processes	   within	   the	   same	   cell,	   such	   as	   the	   induction	   of	   p21	   for	   cell	   cycle	  regulation	   or	   Sox17	   for	   endoderm	   specification.	   These	   experiments	   could	   indicate	   if	  Smad2/3	   has	   a	   generic	   function	   in	   transcriptional	   regulation	   such	   as	   recruiting	  epigenetic	   regulators	   or	   if	   its	   function	   varies	   in	   the	   context	   of	   different	   genes	   and	  protein	  complexes.	  	  	  
Activin/Nodal	  signaling	  in	  adult	  tissue	  stem	  cells	   	  	  Many	  organs	  harbor	   stem	   cells	   that	   function	   in	   tissue	  maintenance	   and	   injury	   repair.	  These	  stem	  cells	  replenish	  specialized	  cell	  types	  throughout	  development	  and	  adult	  life	  either	   by	   constant	   cell	   divisions	   (e.g.	   intestinal	   stem	   cells)	   (Li	   and	  Clevers,	   2010)	   or	   by	  transient	   activation	  when	  needed	   (e.g.	   hematopoietic	   system,	   hair	   follicles,	  mammary	  gland)(Fuchs,	   2009;	   Lange	   and	   Calegari,	   2010) (Orford	   and	   Scadden,	   2008).	   The	   TGFβ	  superfamily	   is	   involved	   in	  self-­‐renewal	  of	  adult	  stem	  cells	   in	  many	  of	   these	  tissues.	  At	  
	   16	  
high	   levels,	   TGFβ	   usually	   inhibits	   cell	   proliferation	   in	   a	   reversible	   manner	   and	   this	  might	  be	  particularly	  relevant	  for	  the	  regulation	  of	  quiescent	  state	  and	  re-­‐entry	  of	  adult	  stem	   cells	   into	   cell	   cycle	   (Massague,	   2012;	   Tumbar	   et	   al.,	   2004).	   	   The	  mechanism	   by	  which	  TGFβ	  regulates	  the	  cell	  cycle	  is	  described	  further	  below.	  However,	  the	  function	  of	  Activin/Nodal	  signalling	  in	  the	  self-­‐renewal	  or	  differentiation	  of	  adult	  stem	  cells	  is	  less	  clear,	   despite	   several	   recent	   reports	   suggesting	   a	   key	   role	   (Cambray	   et	   al.,	   2012;	  Dunphy	  et	  al.,	  2011;	  Kadaja	  et	  al.,	  2014).	   Indeed,	   the	  expression	  of	  Nodal	  seems	  to	  be	  limited	  to	  certain	  tissues	  which	  undergo	  considerable	  remodeling	  such	  as	  endometrium,	  placenta	   and	   lactating	  mammary	   gland	   (Quail	   et	   al.,	   2013;	   Strizzi	   et	   al.,	   2012),	  which	  suggests	  that	  Nodal	  might	  not	  be	  involved	  in	  the	  maintenance	  and	  specification	  of	  many	  adult	  stem	  cells,	  in	  contrast	  to	  TGFβ,	  more	  widely	  expressed.	  ,	  Activin	  transcripts	  can	  be	  detected	   in	   a	   diversity	   of	   tissues	   including	   the	   pituitary	   gland,	   the	   spleen,	   the	   bone	  marrow	  and	  specific	  parts	  of	  the	  brain	  (Luisi	  et	  al.,	  2001),	  but	  functions	  in	  cell	  cycle	  are	  yet	   to	  be	   fully	   investigated.	  Due	   to	  difficulties	   in	   the	  reliable	  detection	  of	  Activins	  and	  Nodal	  expression	  	  with	  the	  possibility	  of	  alternative	  splice	  variants	  for	  the	  latter	  (Strizzi	  et	  al.,	  2012),	   further	  studies	  are	  needed	  to	  generalize	   these	  observations	   to	  a	  broader	  range	  of	  adult	  tissues	  and	  sub-­‐populations	  of	  cells	  in	  each	  tissue.	  Here,	   we	   discuss	   key	   examples	   where	   Activin/Nodal	   signalling	   is	   known	   to	   be	  important	   in	   adult	   stem	   cells,	   and	   where	   the	   related	   TGFβ	   pathway	   plays	   roles	   that	  share	  parallels	  with,	  or	  may	  shed	  light	  on,	  the	  functions	  of	  Activin/Nodal	  in	  these	  stem	  cell	  systems.	  	  	  
Hair	  follicle	  stem	  cells.	  In	   adult	   tissues,	   there	   are	   instances	   where	   Activin	   signalling	   has	   a	   specific	   role	   in	  maintaining	   cell	   “stemness”	   while	   the	   function	   of	   TGFβ	   seems	   to	   be	   less	   important.	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Indeed,	  the	  absence	  of	  TGFβ	  receptor	  II	  in	  mouse	  skin	  epithelium	  does	  not	  induce	  large	  changes	  during	  normal	  homeostasis	  (Guasch	  et	  al.,	  2007;	  Oshimori	  and	  Fuchs,	  2012b).	  In	  contrast,	  conditional	  ablation	  of	  the	  Activin	  receptor	  type	  1B	  (Alk4	  or	  Acvr1b)	  causes	  the	  degeneration	  of	  hair	  follicles	  and	  the	  formation	  of	  cysts	  with	  keratinaceous	  debris.	  Therefore,	  despite	  their	  similarities	  and	  common	  effectors,	  TGFβ	  and	  Activin	  signalling	  appear	  to	  control	  different	  mechanisms	  in	  skin	  stem	  cells	  (Qiu	  et	  al.,	  2011).	  Accordingly,	  the	   self-­‐renewal	   of	   hair	   follicle	   stem	   cells	   and	   the	   suppression	   of	   epidermal	  differentiation	  involves	  Activin	  B	  and	  several	  other	  genes	  that	  are	  known	  to	  be	  involved	  in	   enhancing	  Activin	   signalling	   such	  as	  Wwp2,	  S100A4,	  Sulf2,	   and	   Inhbb	  (Kadaja	   et	   al.,	  2014).	  The	  expression	  of	   these	  genes	   is	  also	  controlled	  by	  Sox9,	  a	  central	  regulator	  of	  hair	  follicle	  stem	  cells.	  In	  turn,	  administration	  of	  Activin	  B	  can	  partially	  compensate	  for	  the	   loss	   of	   Sox9	   in	   the	  hair	   follicle	  niche	   by	  blocking	   the	  premature	  differentiation	  of	  hair	  follicle	  stem	  cells	  (Kadaja	  et	  al.,	  2014).	  It	  would	  be	  interesting	  to	  determine	  if	  the	  switch	  between	  quiescent	   and	  active	   states	  of	   hair	   follicle	   stem	  cells	   involves	   specific	  cell	   cycle	   regulators	   of	   the	   INK4	   and	   KIP/CIP	   family	   such	   as	   p15	   or	   p21,	   which	   are	  known	  to	  be	  regulated	  by	  the	  cytostatic	  response	  of	  TGFβ	  signalling	  in	  various	  cells.	  In	  addition,	  the	  precise	  effect	  of	  Smad2/3	  inhibition	  on	  cell	  fate	  decision	  in	  skin	  stem	  cells	  could	   also	   reveal	   novel	   functions	   of	   Activin	   signalling	   in	   their	   self-­‐renewal	   and	   their	  capacity	  of	  differentiation.	  	  
Hematopoietic	  Stem	  Cells	  	  In	  most	   adult	   stem	   cells	   such	   as	   hematopoietic	   stem	   cells	   or	   neural	   stem	   cells	  where	  TGFβ	   signalling	  plays	  an	   important	   role,	   the	   involvement	  of	  Activin	  or	  Nodal	   remains	  unclear.	   Nevertheless,	   as	   TGFβ	   and	   Nodal/Activin	   pathways	   share	   receptors	   and	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transduction	   proteins,	   we	   will	   briefly	   summarise	   the	   function	   of	   TGFβ	   signalling	   in	  these	  stem	  cells	  and	  draw	  parallels	  between	  these	  two	  closely	  related	  pathways.	  Adult	   Hematopoietic	   Stem	   Cells	   (HSCs)	   reside	   in	   the	   bone	   marrow	   among	  progenitors	   at	   different	   stages	   of	   the	   hematopoietic	   lineage	   (Orkin	   and	   Zon,	   2008;	  Zhang	  et	  al.,	  2008).	  TGFβ	  signaling	  pathway	  has	  long	  been	  implicated	  in	  regulating	  HSC	  quiescence	  (Fortunel	  et	  al.,	  2000;	  Yamazaki	  et	  al.,	  2006).	  It	  functions	  by	  upregulating	  the	  transcription	   of	   the	   cyclin-­‐dependent	   kinase	   (CDK)	   inhibitor	   p57	   and	   suppressing	  PI3K/Akt	   signaling,	   thus	   preventing	  HSC	   re-­‐entry	   into	   the	   cell	   cycle	   (Yamazaki	   et	   al.,	  2006).	   The	   latent	   TGFβ	   present	   in	   the	   bone	   marrow	   seems	   to	   be	   activated	   by	   non-­‐myelinating	  Schwann	  cells	  (Yamazaki	  et	  al.,	  2011)	  and	  the	  TGFβ	  response	  is	  mediated	  by	  TβRII	  receptors	  leading	  to	  Smad2/3	  phosphorylation.	  	  Of	  note,	  HSCs	  are	  not	  a	  homogenous	  population	  of	  cells	  but	  instead	  can	  be	  divided	  into	   at	   least	   two	   distinct	   subtypes	   which	   have	   unique	   self-­‐renewal	   properties	   and	  exhibit	  biased	  differentiation	  towards	  different	  mature	  hematopoietic	  lineages	  (Dykstra	  et	   al.,	   2007;	   Lemischka	   et	   al.,	   1986;	   Sieburg	   et	   al.,	   2006).	   Interestingly,	   these	   HSC	  subpopulations	  have	  distinct	  cellular	  responses	   to	  TGFβ	  signalling,	  which	  affects	   their	  cell	  cycle	  state	  (discussed	  below)	  and	  thus	  their	  proliferation	  capacities	  (Challen	  et	  al.,	  2010).	   Therefore,	   the	   switch	   model	   proposed	   for	   pluripotency/endoderm	  differentiation	   for	  Activin/Nodal-­‐Smad2/3	   in	  PSCs	   appears	   to	  be	   applicable	   to	  BMP4-­‐Smad1/5/8	   in	   HSCs.	   R-­‐Smads	   could	   therefore	   operate	   in	   a	   similar	   manner	   in	   HSCs	  hematopoietic	  specification	  and	  in	  hPSCs	  early	  germ	  layer	  differentiation.	  	  Overall,	   TGFβ	   signaling	   exhibits	   an	   essential	   function	   in	   controlling	   the	   self-­‐renewal	  of	  stem	  cells	  in	  various	  adult	  tissues	  such	  as	  the	  skin,	  the	  hematopoietic	  system	  and	   the	   central	   nervous	   system.	   Interestingly,	   Activin/Nodal	   signaling	   could	   have	  complementary	  functions	  in	  self-­‐renewal	  and	  differentiation	  of	  adult	  stem	  cells.	  Further	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investigations	  including	  tissue	  specific	  gene	  knock	  out	  for	  Nodal	  and	  the	  Inhibins	  could	  help	   to	   further	   understand	   the	   specificity	   of	   each	   of	   these	   growth	   factors	   in	   organ	  homeostasis	  and	  tissue	  repair.	  
	  
Activin/Nodal	  signaling	  in	  cancer	  and	  metastasis	  Cancer	  stem	  cells	  (CSCs)	  can	  give	  rise	  to	  a	  new	  tumor	  which	  shows	  similar	  features	  to	  its	   parental	   tumor.	   CSCs	   have	   been	   identified	   in	   various	   cancer	   types	   including	  pancreatic	   cancer,	   melanoma,	   glioma,	   chronic	   myeloid	   leukemia	   and	   malignant	  squamous	  cell	  carcinoma	  (Chen	  et	  al.,	  2008;	  Driessens	  et	  al.,	  2012;	  Schepers	  et	  al.,	  2012;	  Schober	   and	   Fuchs,	   2011).	   A	   number	   of	   mutations	   leading	   to	   cancer	   affect	   genes	  involved	   in	   the	   Activin/Nodal/TGFβ	   signaling	   pathways	   including	   ACVRI,	   TGFBRI/II,	  Smad2	   and	   Smad4	   (Massague,	   2008).	   These	  mutations	   tend	   to	   accumulate	   in	   tissue-­‐specific	   stem	   cells	   due	   to	   their	   longevity	   (Lobo	   et	   al.,	   2007).	   Interestingly,	   the	   role	   of	  Activin/Nodal	   signalling	   in	   tumorigenesis	   and	   cancer	   stem	   cells	   often	   reflects	   the	  function	   of	   this	   pathway	   in	   embryonic	   development	   or	   in	   adult	   tissue	   homeostasis.	  Indeed,	  the	  Activin/Nodal	  pathway	  regulates	  self-­‐renewal	  and	  differentiation	  of	  cancer	  stem	  cells,	  and	  increases	  the	  plasticity	  and	  metastatic	  potential	  of	  tumour	  cells	  (Lonardo	  et	  al.,	  2011;	  Spiller	  et	  al.,	  2012;	  Topczewska	  et	  al.,	  2006).	  Accordingly,	   the	  mutation	  of	  the	   inhibin	   a	   subunit	   (an	   Activin	   inhibitor)	   in	   the	   mouse	   gonad	   results	   in	  stromal/granulosa	  tumour	  suggesting	  that	  Activin	  signalling	  could	  be	  tumorigenic	  if	  not	  tightly	   controlled	   (Matzuk	   et	   al.,	   1992).	   Similarly,	  Nodal	   is	   expressed	   in	   a	  diversity	   of	  tumors	  including	  melanoma,	  prostate,	  breast	  and	  testicular	  cancer	  (Hardy	  et	  al.,	  2010;	  Lawrence	   et	   al.,	   2011;	   Lonardo	   et	   al.,	   2011;	   Spiller	   et	   al.,	   2012;	   Strizzi	   et	   al.,	   2012;	  Topczewska	   et	   al.,	   2006)	   which	   degree	   of	   malignancy	   correlates	   with	   the	   amount	   of	  secreted	  Nodal	  (Spiller	  et	  al.,	  2012).	  In	  addition,	  the	  Nodal	  co-­‐receptor	  Cripto	  is	  widely	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overexpressed	   in	   tumor	   cells	   from	   many	   different	   origins	   and	   correlates	   with	  invasiveness	   and	   poor	   prognosis	   in	   melanoma,	   pancreatic	   cancer,	   breast	   cancer	   and	  testicular	  cancer	  (Lonardo	  et	  al.,	  2011;	  Postovit	  et	  al.,	  2008).	  	  In	   melanoma,	   Nodal	   signalling	   also	   promotes	   the	   vascularisation	   of	   the	   tissue	  surrounding	   the	   tumor,	   which	   might	   be	   responsible	   for	   the	   malignancy	   and	   high	  incidence	   of	  metastases	   due	   to	   increased	   invasiveness	   in	   these	   cancers	   (Hardy	   et	   al.,	  2010;	  Seftor	  et	  al.,	  2012).	  A	  similar	  vascularisation-­‐promoting	  effect	  has	  been	  noted	  for	  breast	   cancers:	  Nodal	   signalling	   leads	   to	   the	  upregulation	  of	  pro-­‐angiogenic	   factors	   in	  the	  tissue	  surrounding	  the	  tumor	  cells	  (Quail	  et	  al.,	  2013).	  Based	  on	  these	  observations,	  it	  is	  tempting	  to	  hypothesise	  that	  abnormally	  high	  activation	  of	  Nodal	  signalling	  in	  adult	  stem	  cells,	  combined	  with	  genetic	  mutations	  could	  result	  in	  increased	  proliferation	  but	  also	   resistance	   to	   differentiation,	   thereby	   mimicking	   the	   mechanisms	   maintaining	  pluripotency	   of	   hPSCs.	   Future	   investigations	   including	   Smad2/3	   ChIP-­‐Seq	   and	  proteomic	   analyses	   in	   cancer	   stem	   cells	   will	   be	   useful	   to	   compare	   the	   mechanisms	  involving	  Activin/Nodal	  signalling	  in	  self-­‐renewal	  and	  differentiation	  during	  embryonic	  development	  and	  tumorigenesis.	  
	  
Cell	  cycle	  regulation	  Although	  TGFβ	  is	  a	  know	  cytostatic	  factor	  (which	  inhibits	  cell	  growth	  and	  proliferation)	  (Massague,	  2004)	   .	  Accordingly,	  TGFβ	  pathway	  has	  a	  prominent	  role	   in	  regulating	  cell	  cycle	   progression	   in	   many	   cell	   types	   and	   it	   acts	   as	   a	   central	   pathway	   for	   mediating	  cytostatic	   responses.	   In	   most	   cases,	   it	   triggers	   potent	   anti-­‐proliferative	   effects	   by	  inducing	  the	  expression	  of	  cyclin	  dependent	  kinase	  inhibitors	  (CDKIs)	  of	  the	  INK4	  (p14,	  p15,	  p16,	  p18,	  p19)	  or	  KIP/CIP	  (p21,	  p27,	  p57)	  protein	  family	  (Massague,	  2008).	  These	  cell	  cycle	  inhibitors	  usually	  cause	  the	  cells	  to	  reversibly	  arrest	  in	  G1	  phase	  but	  they	  can	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also	   lead	   to	   terminal	  differentiation	  (Evans	  et	  al.,	  2003)	  or	  programmed	  cell	  death.	  Of	  note,	  this	  function	  of	  the	  TGFβ	  signaling	  pathway	  could	  be	  inhibited	  by	  SNON	  or	  SKI	  in	  hPSCs	  (Tsuneyoshi	  et	  al.,	  2012)	  since	  these	  genes	  are	  known	  to	  limit	  the	  transcriptional	  activity	  of	  Smad2/3	  and	  especially	   to	  block	   induction	  of	  CDKi	   such	  as	  p21	   (Zhu	  et	  al.,	  2007).	   	   Importantly,	   Activins	   are	   known	   to	   control	   cell	   cycle	   by	   similar	   CDKIs	  dependent	  mechanisms	  (Chen	  et	  al.,	  2002)	  thereby	  suggesting	  an	  overlapping	  function	  between	  TGFbeta	   and	  Activin	   signaling	   in	   proliferation	   control.	  Nodal	   function	   in	   cell	  cycle	  control	  remain	  to	  be	  fully	  investigated	  especially	  since	  Nodal	  seems	  to	  potentiate	  the	  plasticity	  and	  metastatic	  capacity	  of	  CSC.	  Moreover,	   the	   interplays	   between	   Activin/Nodal/TGFbeta	   signaling	   and	   cell	   cycle	  regulations	  are	  certainly	  more	  complex	  especially	   in	   the	  context	  of	  stem	  cells.	   Indeed,	  our	   group	   and	   others	   have	   shown	   that	   Activin	   signalling	   in	   human	   pluripotent	   stem	  cells	   could	   be	   directly	   controlled	   by	   Cyclin	   D	   /	   CDK	   complexes	   which	   can	   limit	   the	  shuttling	   of	   Smad2/3	   into	   the	   nucleus.	   Thus,	   these	   cycle	   regulators	   restrain	   the	  inductive	   effects	   of	  Activin/Nodal	   signaling	   on	   endoderm	  differentiation	   (Pauklin	   and	  Vallier,	  2013).	  This	  mechanism	  enables	  cell	  cycle	  specific	  regulation	  of	  cell	  fate	  choice	  in	  hESCs.	  Endoderm	  differentiation	  can	  only	  be	  induced	  in	  early	  G1	  phase	  when	  Cyclin	  Ds	  are	  expressed	  at	   low	   levels	  while	  neuroectoderm	  specification	  can	  only	  be	   induced	   in	  late	   G1	   phase	  when	   Cyclin	  Ds	   are	   highly	   expressed.	   These	  mechanisms	   could	   also	   be	  important	   for	   a	   number	   of	   somatic	   stem	   cells	   since	   functional	   studies	   have	  demonstrated	   that	   loss	   of	   function	   of	   Cyclin	   D/CDK	   results	   in	   the	   lengthening	   of	   G1	  phase	  in	  neuronal	  stem	  cells	  in	  vivo	  while	  increasing	  their	  differentiation	  into	  neurons	  (Lange	  and	  Calegari,	  2010;	  Lange	  et	  al.,	  2009).	  Similarly,	  absence	  of	  Cyclin	  Ds	  or	  CDK4/6	  results	   in	   premature	   differentiation	   of	  Hematopoietic	   Stem	  Cells	   (Lange	   and	  Calegari,	  2010).	  Considered	  together,	  these	  studies	  highlight	  a	  complex	  relationship	  between	  cell	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Perspectives	  Activin/Nodal	   signaling	   has	   been	   shown	   to	   control	   various	   mechanisms	   in	  different	  model	  organisms	  and	  in	  a	  diversity	  of	  cell	  types.	  The	  function	  of	  this	  pathway	  in	   pluripotent	   stem	   cells	   remains	   relatively	   recent	   and	   opens	   new	   perspectives	   to	  understand	   the	   cross	   talk	   between	   cell	   cycle,	   cell	   fate	   decisions,	   and	   epigenetic	  regulation.	   It	   is	   of	   course	   tempting	   to	   hypothesize	   that	   these	   mechanisms	   could	   be	  conserved	   in	   adult	   stem	   cells	   and	   ultimately	   constitute	   the	   central	   unit	   defining	  “stemness”.	  	  Indeed,	  Activin,	  Nodal	  or	  TGFβ	  growth	  factors	  are	  found	  in	  various	  tissues	  and	  their	  activity	  is	  essential	  for	  a	  number	  of	  cell	  types.	  However,	  mechanistic	  insight	  on	  the	   function	   of	   these	   signaling	   molecules	   in	   self-­‐renewal/cell	   fate	   decisions	   is	   still	  
	   23	  
lacking.	   The	   technical	   challenge	   to	   perform	   tissue	   specific	   genetic	   studies	   in	   animal	  models	  explains	  in	  part	  this	  situation.	  The	  importance	  of	  other	  signaling	  pathways	  such	  as	  Wnt	  might	  have	  also	  obscured	  the	  role	  of	  Activin/Nodal/TGFβ	  in	  these	  mechanisms.	  Finally,	  the	  dominant	  function	  of	  TGFβ	  in	  cell	  cycle	  regulation	  might	  mask	  its	  role	  in	  in	  regulating	  cell	  fate	  decisions	  in	  multipotent	  stem	  cells.	  Indeed,	  gain	  or	  loss	  of	  function	  of	  TGFβ	  signaling	  members	  often	  results	  in	  uncontrolled	  proliferation	  or	  quiescence,	  both	  of	   which	   indirectly	   affect	   cell	   fate	   decisions,	   thereby	   masking	   any	   potential	   role	   for	  these	   factors	   in	   differentiation.	   The	   availability	   of	   new	   culture	   systems	   to	   maintain	  somatic	  stem	  cells	  in	  vitro	  such	  as	  the	  3D	  organoid	  approach	  (Sato	  and	  Clevers,	  2013),	  associated	  with	   efficient	   genome	  editing	  methods	   such	   as	  CRISPR	   	   (Cong	   et	   al.,	   2013;	  Mali	   et	   al.,	   2013)	   could	   provide	   new	   opportunities	   to	   delineate	   the	   contribution	   of	  Activin/Nodal/TGFβ	   in	   the	   self-­‐renewal	   of	   adult	   stem	   cells	   and	   their	   differentiation	  toward	  functional	  cell	  types	  during	  organ	  homeostasis.	  	  In	  parallel,	  human	  pluripotent	  stem	  cells	  represent	  a	  unique	  opportunity	  to	  study	  the	   molecular	   mechanisms	   controlling	   Activin/Nodal	   functional	   activity	   and	   cellular	  specificity	  in	  self-­‐renewal	  and	  differentiation.	  Indeed,	  Activin/Nodal	  signaling	  pathway	  seems	   to	  be	  constantly	  controlling	  opposite	  cellular	  mechanisms	  such	  as	  proliferation	  vs	   quiescence,	   self-­‐renewal	   vs	   differentiation	   and	   tumorigenesis	   vs	   apoptosis.	  Furthermore,	   a	   large	  number	  of	  genes	  with	  apparently	  divergent	   functions	  have	  been	  identified	   as	   targets	   for	   Activin/Nodal-­‐Smad2/3	   signalling,	   for	   example	   Nanog	  (pluripotency)	   and	   Sox17	   (endoderm	   differentiation).	   Although	   this	   was	   initially	  counter-­‐intuitive,	  it	  is	  now	  evident	  that	  Activin/Nodal	  signaling	  activity	  is	  mediated	  by	  lineage	  specific	  transcription	  factors	  that	  help	  targetting	  the	  Smad2/3	  complex	  and	  co-­‐regulator	   complexes	   to	   specific	   loci	   in	   a	   context-­‐dependent	   manner.	   However,	   such	  models	   also	   raise	   questions	   concerning	   the	   molecular	   function	   of	   Smad2/3	   in	   these	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protein	   complexes,	   which	   control	   conflicting	   aspects	   of	   cellular	   biology.	   Indeed,	   it	  remains	   to	   be	   uncovered	   if	   the	   Smad2/3	   complex	   is	   only	   necessary	   to	   build	  transcriptional	  complexes	  controlling	  the	  expression	  of	  different	  set	  of	  genes	  or	  if	  it	  has	  more	   direct	   function	   by	   controlling	   the	   activity	   of	   key	   transcription	   factors	   and	  epigenetic	   modifiers.	   Furthermore,	   the	   number	   of	   Smad2/3	   partners	   continues	   to	  increase	  with	  very	   little	  overlap	  between	  different	  cell	   types.	  Proteome-­‐wide	  analyses	  are	  yet	  to	  reveal	  the	  full	  list	  of	  Smad2/3	  binding	  partners,	  and	  thus	  the	  complexity	  and	  diversity	   of	   protein-­‐protein	   interactions	   involving	   Smad2/3	   are	   likely	   to	   be	  underestimated.	   Identification	  of	  Smad2/3	  binding	  partners	  at	  various	  developmental	  stages	   and	   in	   stem	   cells	   will	   help	   clarifying	   why	   Smad2/3	   has	   so	   many	   apparently	  distinct	   functions	   in	   different	   developmental	   contexts	   and	   how	   this	   diversity	   is	  mechanistically	  achieved.	  To	   conclude,	   TGFβ/Activin/Nodal	   pathways	   function	   not	   only	   in	   cell	   fate	   choice	  during	   embryogenesis	   but	   also	   in	   cell	   cycle	   regulation	   and	   adult	   tissue	   homeostasis.	  Since	   cross-­‐talk	   between	   cell	   cycle	   regulation,	   self-­‐renewal	   and	   differentiation	   is	  essential	   for	   controlling	   the	   function	   of	   stem	   cells	   during	   development	   and	   in	   adult	  organs,	  the	  TGFβ/Activin/Nodal	  pathways	  may	  function	  as	  a	  direct	  link	  between	  these	  fundamental	   processes.	   Further	   research	   will	   be	   necessary	   to	   demonstrate	   the	  importance	  of	  these	  mechanisms	  in	  normal	  regenerative	  process	  and	  in	  the	  formation	  of	  cancer	   stem	   cells.	   Thus,	   a	   more	   complete	   picture	   of	   the	   mechanistic	   aspects	   of	  Activin/Nodal	   signaling	   in	   stem	   cells	   could	   help	   to	   develop	   new	   regenerative	  approaches	  and	  unveil	  novel	  therapeutic	  targets	  for	  the	  treatment	  of	  cancer.	  	  	  
Box	  1.	  Spatio-­‐temporal	  effects	  of	  Activin/Nodal	  concentration	  gradients.	  Activin	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and	  Nodal	  ligands	  have	  short-­‐range	  effects	  on	  nearby	  cells	  as	  well	  as	  long-­‐range	  effects	  during	  development	  (Smith	  et	  al.,	  2008).	  As	  an	  example	  of	  short-­‐range	  effect,	  Nodal	  is	  positively	  autoregulated	  by	  Smad2/3	  via	  an	  asymmetric	  enhancer	   located	   in	   its	   first	  intron	  (Adachi	  et	  al.,	  1999)	  and	  via	  an	  upstream	  left-­‐side	  specific	  enhancer	  (Saijoh	  et	  al.,	  2003).	  For	   long-­‐range	  effects,	  Nodal	   is	  secreted	  by	  node	  cells	  and	  can	  activate	   its	  target	  genes	  in	  distant	  cells	  of	  the	  lateral	  plate	  mesoderm	  (Oki	  et	  al.,	  2007).	  The	  Nodal	  effect	   is	  also	  dose-­‐dependent	  since	   low	  levels	  of	  Nodal	  are	  sufficient	  to	   induce	  target	  genes	   such	   as	   Brachyury/T,	   whereas	   Goosecoid	   is	   only	   activated	   by	   high	   levels	   of	  Nodal	   during	   mesoderm	   and	   endoderm	   patterning	   (Gurdon	   and	   Bourillot,	   2001;	  Schier	   and	   Talbot,	   2005).	   Nodal	   forms	   concentration	   and	   activity	   gradients	   during	  development	   that	   provides	   positional	   information,	   which	   ultimately	   directs	   the	   cell	  fate	  decision	  of	  the	  target	  cells	  (Brennan	  et	  al.,	  2001).	  This	  is	  particularly	  evident	  in	  the	  formation	  of	  vegetal-­‐animal	  axis	  (Faure	  et	  al.,	  2000;	  Gritsman	  et	  al.,	  2000;	  Harvey	  and	  Smith,	  2009).	  The	  time	  of	  Nodal	  signaling	  is	  also	  important	  for	  cell	  fate	  decisions	  since	  duration	   of	   Nodal	   signaling	   has	   different	   effects	   and	   results	   in	   the	   generation	   of	  different	  cell	   types	   (Hagos	  and	  Dougan,	  2007).	  Of	  note,	   the	  spatiotemporal	  effects	  of	  Activin/Nodal	   concentration	   gradients	   have	   yet	   to	   be	   taken	   into	   account	   in	   vitro.	  Indeed,	  protocols	  of	  differentiation	  use	   large	  doses	  of	  Activin	  and	  2D	  culture	  system,	  which	  are	  likely	  to	  bypass	  the	  regulation	  of	  gradient	  formation.	  This	  could	  result	  in	  the	  absence	  of	  positional	  information	  during	  in	  vitro	  specification	  and	  represent	  one	  of	  the	  challenges	  for	  generating	  specific	  cell	  types	  from	  hPSCs.	  	  	  




Pathway	   Gene	  name	  
Binding	  
partners	   Function	  
Ligands	   Nodal	  	  	  
Nodal	  (human,	  mouse,	  bird),	  cyclops,	  squint,	  
southpaw	  (fish),	  ×nr1,	  
×nr2,	  ×nr4,	  ×nr5,	  ×nr6	  (frog)	  	   Nodal	  pathway	  inhibitors	  
Nodal-­‐related	  TGFβ	  ligands,	  activate	  signalling	  	  
Gdf1	  (mouse)	  	   Ligand,	  activates	  signalling	  	  	  Gdf3	  (mouse)	  	  Vg1	  (frog,	  fish,	  bird)	  	  Activin	  	   Activin	  bA,	  bB,	  bC,	  bE	  (human)	   Follistatin	   Ligand,	  activates	  signalling	  	  Receptors	  	   Nodal	  	   ALK4,	  ALK7	  	   ActRII,	  ActRIIB,	  	  Co-­‐ Type	  I	  serine-­‐threonine	  kinase	  receptor	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receptors	  
ActRII,	  ActRIIB	  	   ALK4,	  ALK7	  	   Type	  II	  serine-­‐threonine	  kinase	  receptors	  
Activin	   ALK4	   ActRII	   Type	  I	  serine-­‐threonine	  kinase	  receptor	  
ActRII	   ALK4	  	   Type	  II	  serine-­‐threonine	  kinase	  receptors	  
Co-­‐receptors	   Nodal	  	  
Cripto	  (human),	  
Cryptic	  (mouse),	  one-­‐
eyed	  pinhead	  (fish),	  
FRL-­‐1/×CR1,	  ×CR2,	  
×CR3	  (frog)	  	  
ALK4	  	  
EGF-­‐CFC	  co-­‐receptors,	  necessary	  for	  activating	  Nodal	  signalling	  but	  inhibits	  Activin	  signalling	  
Inhibitors	   Nodal	  	  
Lefty1,	  Lefty2	  	   Nodal	  pathway	  ligands	  	  
Inhibit	  Nodal	  signalling	  by	  interacting	  with	  Nodal	  ligands	  and	  EGF-­‐CFC	  co-­‐receptors.	  	  
Cer1,	  Cer2,	  Gremlin	  	   Cerberus/DAN	  family	  members;	  Inhibit	  signalling	  by	  interacting	  with	  Nodal	  ligands	  Activin	   Follistatin	   Activin	   Inhibits	  signalling	  by	  binding	  to	  Activins	  	  
Intracellular	  transduction	  proteins	   Nodal,	  Activin	  	  	  
Smad2	   Smad3,	  Smad4	   Receptor-­‐Smads;	  Regulate	  gene	  transcription	  and	  cell	  cycle	  (hPSCs,	  endoderm	  differentiation,	  reproductive	  tissues)	  Smad3	   Smad2,	  Smad4	  
Smad4	  	   Smad2,	  Smad3	  	   Co-­‐Smad,	  helps	  transporting	  Smad2	  and	  Smad3	  into	  the	  nucleus	  Smad7	   Smad2,	  Smad3	   Inhibitory-­‐Smad,	  blocks	  the	  activity	  of	  Smad2	  and	  Smad3	  	  
	  




member	   Tissue	  type	  
Interacting	  
protein	   Function	  
Target	  loci	  
Activin/Nodal	  	  
Smad2,	  Smad3	   Human	  pluripotent	  stem	  cell	  	  
Nanog	   Maintenance	  of	  pluripotency	  	  	   Pluripotency	  genes	  (Oct4,	  Nanog)	  Smad2,	  Smad3	   Oct4	  
Smad2,	  Smad3	   P300	   Transcriptional	  activation	  by	  histone	  acetylation	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Figure	  Legends.	  	  Figure	  1.	  Components	  of	  Activin/Nodal.	  Extracellular	  ligands	  Activin	  or	  Nodal	  bind	  to	  type	  I	  (ACVRIIA/IIB)	  and	  type	  II	  transmembrane	  receptors	  (Alk4/7)	  while	  TGFβ	  growth	  factors	  bind	  to	  TGFBRI	  and	  TGFBRII/Alk5.	  Nodal	  requires	  the	  additional	  binding	  of	  the	  transmembrane	  co-­‐receptor	  CRIPTO	  to	  form	  an	  activated	  receptor	  complex	  with	  type	  I	  and	   type	   II	   receptors.	   The	   activated	   receptor	   complex	   (both	   for	   Activin/Nodal	   and	  TGFβ pathways)	  phosphorylates	  Smad2	  and	  Smad3	  proteins,	  which	  enter	  the	  nucleus	  in	  
Smad2,	  Smad3	   SnoN	   Inhibition	  of	  differentiation	  	   Endoderm	  genes	  	  Smad2,	  Smad3	  
Mesendoderm	  	  
EOMES	  
Induction	  of	  endoderm	  	  	  
Endoderm	  genes	  	  	  
Smad2,	  Smad4	   FOXH1	   GSC	  (Smad2	  activates,	  Smad3	  represses)	  	  Smad2,	  Smad3	   GSC	   Endoderm	  genes	  	  	  Smad2,	  Smad3	   Mesoderm	   Mixer	   Mesoderm	  induction	   Mesoderm	  genes	  
TGFβ	  	  
Smad3	   Myotube	   MyoD1	   Myocyte	  identity	   Myocyte	  genes	  Smad3	   Pro-­‐B-­‐cell	   Pu.1	   Pro-­‐B-­‐cell	  maturation	   B-­‐cell	  specific	  genes	  Smad2,	  Smad3,	  Smad4	   Keratinocyte	  	   FOXO3	  
Cell	  cycle	  inhibition	  	  	  
CDK	  inhibitors	  p15Ink4b,	  p21Cip1	  Smad2,	  Smad3,	  Smad4	   Keratinocyte	  	   E2F4/5	   Myc	  Smad2,	  Smad3,	  Smad4	   Epithelial	  cells	  	   C/EBPbeta	   CDK	  inhibitor	  p15Ink4b	  Smad2,	  Smad3,	  Smad4	   Epithelial	  cells	  	   Sp1	   p15Ink4b	  Smad2	   Epithelial	  cells	  	   ATF3	   Id1	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complex	  with	  Smad4.	   Smad	  proteins	   are	   targeted	   to	  distinct	   loci	  by	   sequence	   specific	  transcription	  factors	  which	  are	  often	  expressed	  in	  a	  cell	  type-­‐dependent	  manner.	  Smad	  proteins	   act	   as	   transcriptional	   regulators	   and	   are	   able	   to	   induce	   or	   repress	   the	  transcription	  of	   their	   target	   loci	  by	   recruiting	  epigenetic	  modifiers,	  which	  will	   further	  modulate	   the	   accessibility	   of	   the	   surrounding	   chromatin	   by	   inducing	   epigenetic	  modifications	  on	  histones	  or	  DNA.	  In	  some	  cells	  types,	  Smad2	  and	  Smad3	  proteins	  can	  interact	   with	   Smad1,	   Smad5	   or	   Smad8,	   which	   usually	  mediate	   Bmp4	   signalling,	   thus	  mediating	  the	  crosstalk	  between	  Activin/Nodal	  and	  Bmp	  signaling	  pathway.	  	  	  
Figure	  2.	  The	  functional	  domains	  and	  sites	  of	  post-­‐translational	  modifications	  on	  
Smad2/3	   and	   Smad4	   proteins.	   Smad	   proteins	   contain	   three	   distinct	   functional	  domains:	  the	  N-­‐terminal	  MH1	  domain	  (blue),	  the	  middle	  linker	  domain	  (green)	  and	  C-­‐terminal	  MH2	  domain	  (pink).	   	  Smad2/3	  and	  Smad4	  proteins	  not	  only	  act	  as	  important	  effectors	  for	  Activin/Nodal	  signalling	  pathway	  but	  interconnect	  various	  other	  signalling	  pathways	  which	   induce	   post-­‐translational	  modifications	   on	   specific	   residues	   of	   Smad	  proteins.	  Colored	  circle	  -­‐	  phosphorylation	  site,	  colored	  star	  –	  PIAS	  ubiquitinylation	  site,	  colored	   square	   -­‐	   ubiquitinylation	   site,	   colored	  diamond	   -­‐	   p300	   interaction	   site.	  NLS	   –	  nuclear	  localisation	  signal,	  NES	  -­‐	  nuclear	  export	  signal,	  DNA	  -­‐	  DNA	  binding	  region.	  	  	  
Figure	  3.	  Signalling	  pathways	  maintaining	  the	  self-­‐renewal	  of	  hESCs.	  Self-­‐renewal	  of	  hESCs	  is	  maintained	  by	  Activin/Nodal	  and	  FGF2	  signalling.	  Self-­‐renewal	  signals	  from	  Activin/Nodal	   signalling	   are	   mediated	   by	   Smad2/3	   proteins	   which	   upon	  phosphorylation	   bind	   to	   Oct4	   and	  Nanog	   proteins	   and	   coregulate	   a	   broad	   number	   of	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genes	   involved	   in	   maintenance	   of	   pluripotency.	   These	   pluripotency	   factors	   including	  Oct-­‐4,	   Nanog	   and	   Sox2,	   in	   turn	   block	   the	   differentiation	   to	   mesendoderm	   and	  neuroectoderm	  while	  coordinating	  the	  self-­‐renewal	  of	  pluripotent	  stem	  cells.	  	  	  Funding:	  	  SP	  is	  supported	  by	  the	  EuFp7	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  Cambridge	  Hospitals	  National	  Institute	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  Research	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  Research	  Center.	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Figure 2. Pauklin et al. Development
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